| Champion Iron Limited (CIA) ORDINARY FULLY PAID |
Materials |
$2,522 |
Third Quarter FY2026 Investor Presentation
|
29 Jan 2026 9:30AM |
$6.340 |
$4.730 |
fallen by
25.39%
|
|
CIA - Price-sensitive ASX Announcement
Full Release
Key Points
- Champion Iron Limited reported a quarterly iron ore concentrate production of 3.7M wmt and record sales of 3.9M dmt.
- The Company experienced robust operational performances, with improved ore recovery rates and elevated mined ore and waste volumes.
- Champion Iron is progressing with the DRPF project to upgrade Bloom Lake’s capacity, with first shipments expected in calendar H1/2026.
- A decrease in cash by $80.4M was observed, primarily due to dividend payments and investments in ongoing projects, offset by operational cash flows.
- Iron ore stockpiles at Bloom Lake decreased due to operational disruptions, but are expected to be sold in the near term.
- Revenue for Q3 FY2026 was reported at $472.3M, with an EBITDA of $152.4M and a net income of $65.0M.
- The Company aims to support its capital return strategy with a larger cash flow base from potential growth opportunities and acquisitions.
- Champion Iron is focused on sustainability and community initiatives, including collaboration with local communities and presentations to government bodies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MEC Resources Limited (MMR) ORDINARY FULLY PAID |
Energy |
$9 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 9:29AM |
$0.006 |
$0.005 |
fallen by
16.67%
|
|
MMR - Price-sensitive ASX Announcement
Full Release
Key Points
- MEC Resources Limited released its Quarterly Activities and Appendix 4C Cash Flow Report for the quarter ending 31 December 2025.
- The company has a non-controlling interest in Advent Energy Ltd, which holds 37.95% of the PEP11 Joint Venture.
- MEC provided additional investment into Advent Energy Ltd in 2025, totaling $1,550,000, with funds used for loans.
- A significant focus remains on clean hydrogen technology, with ongoing efforts to source funding for plant construction in the USA and India.
- There was no net cash from financing activities during the quarter, and the cash and cash equivalents at the end of the period were $1,179,000.
- The company is a registered Pooled Development Fund aiming to invest in small to medium exploration entities.
- MEC Resources Limited remains committed to its investment efforts and developing its resource exploration opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Horizon Oil Limited (HZN) ORDINARY FULLY PAID |
Energy |
$431 |
Quarterly Activities Report
|
29 Jan 2026 9:29AM |
$0.215 |
$0.265 |
risen by
23.26%
|
|
HZN - Price-sensitive ASX Announcement
Full Release
Key Points
- Production and sales volumes increased by 18% and 17% respectively.
- Thailand assets significantly contributed to production and cash flow.
- Net operating cash flow was US$15.8 million.
- Final FY25 dividend payment of AUD 1.5 cents per share.
- Nam Phong Booster Compressor Project reached Final Investment Decision.
- Strong progress on gas supply agreements in Australia.
- Production revenue was US$27.4 million for the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hawk Resources Limited (HWK) ORDINARY FULLY PAID |
Materials |
$20 |
Olympus Scandium Project Update
|
29 Jan 2026 9:29AM |
$0.056 |
$0.038 |
fallen by
32.14%
|
|
| Nova Minerals Limited (NVA) ORDINARY FULLY PAID |
Materials |
$301 |
Notification regarding unquoted securities - NVA
|
29 Jan 2026 9:29AM |
$1.250 |
$0.660 |
fallen by
47.20%
|
|
| Latitude Group Holdings Limited (LFS) ORDINARY FULLY PAID |
Financials |
$977 |
Dividend/Distribution - LFSPA
|
29 Jan 2026 9:29AM |
$1.020 |
$0.940 |
fallen by
7.84%
|
|
| Bass Oil Limited (BAS) ORDINARY FULLY PAID |
Energy |
$26 |
Quarterly Activities Report and Appendix 5B - December 2025
|
29 Jan 2026 9:29AM |
$0.050 |
$0.080 |
risen by
60%
|
|
BAS - Price-sensitive ASX Announcement
Full Release
Key Points
- Bass Oil's quarterly sales reached A$1.75 million, a 7.9% increase, with an average oil price of A$94.38 per barrel.
- Net production for the December quarter was 22,449 barrels, averaging 244 barrels per day.
- Bass signed a gas sales agreement with Origin Energy for the Vanessa gas field, with production starting in 2026.
- The acquisition of the Vanessa gas field is pending regulatory approval.
- Key Performance Metrics showed a 7.4% increase in net production from the previous quarter.
- Bass Oil maintains a debt-free status and has a cash reserve of $0.92 million.
- The Tangai-Sukananti KSO in Indonesia produced 14,396 barrels of oil during the quarter.
- Plans are underway for drilling the Bunian 6 development well in Indonesia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| D3 Energy Limited (D3E) ORDINARY FULLY PAID |
Energy |
$42 |
Quarterly Activities Report and Appendix 5B
|
29 Jan 2026 9:28AM |
$0.350 |
$0.470 |
risen by
34.29%
|
|
D3E - Price-sensitive ASX Announcement
Full Release
Key Points
- Continued work on PR016 Production Right application including EIA and FEED.
- Retesting of Nooitgedacht Major well showed improved gas flow rates.
- Completed audio magnetotelluric surveys for future drilling plans.
- Progressed partnership discussions for Hydrohelix prospect in Arckaringa Basin.
- Held cash reserves of ~$3.5 million as of December 31, 2025.
- Reported key expenditures on exploration, evaluation, and administration.
- Detailed certified gas and helium reserves at ER315.
- Expanded into Australian helium and hydrogen markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Champion Iron Limited (CIA) ORDINARY FULLY PAID |
Materials |
$2,522 |
Interim Consolidated Financial Statements - Dec 31, 2025
|
29 Jan 2026 9:28AM |
$6.340 |
$4.730 |
fallen by
25.39%
|
|
CIA - Price-sensitive ASX Announcement
Full Release
Key Points
- Champion Iron Limited reported net income of CAD 145.55 million for the nine months ended December 31, 2025.
- Total comprehensive income for the same period was CAD 144.32 million.
- Revenues for the nine months ended December 31, 2025, were CAD 1.355 billion.
- The company holds a 51% interest in the Kami Partnership, designed to develop the Kami Project in Canada.
- Champion Iron limited exercised all outstanding warrants during the period, contributing CAD 36.75 million to equity.
- The company made significant investments in property, plant, and equipment, totalling CAD 305.7 million for the period.
- Champion Iron Limited maintained strong liquidity with cash and cash equivalents of CAD 245.09 million as of December 31, 2025.
- Champion Iron Limited experienced a decrease in fair value of its foreign exchange option derivative by CAD 1.269 million.
- Segmented total assets as of December 31, 2025, were CAD 3.429 billion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$312 |
NTA at 23.01.26 Pre-tax 139.8 Post-tax 135.53
|
29 Jan 2026 9:27AM |
$1.270 |
$1.210 |
fallen by
4.72%
|
|
| Control Bionics Limited (CBL) ORDINARY FULLY PAID |
Health Care |
$25 |
PRC-Saltillo - Distribution Agreement
|
29 Jan 2026 9:27AM |
$0.057 |
$0.060 |
risen by
5.26%
|
|
CBL - Price-sensitive ASX Announcement
Full Release
Key Points
- Control Bionics signs distribution agreement with PRC-Saltillo for NeuroNode in the US.
- Agreement is for an initial term of two years.
- PRC to distribute NeuroNode, enhancing AAC solutions for complex communication needs.
- NeuroNode complements existing AAC solutions by detecting small muscle activations.
- PRC has worked with NeuroNode in 2025, with training and demonstrations conducted.
- Strategic partnership aims to expand NeuroNode's US market presence.
- Agreement aligns with Control Bionics' strategic priorities for sales expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fortuna Metals Ltd (FUN) ORDINARY FULLY PAID |
Materials |
$21 |
Trading Halt
|
29 Jan 2026 9:26AM |
$0.115 |
$0.073 |
fallen by
36.52%
|
|
FUN - Price-sensitive ASX Announcement
Full Release
Key Points
- Fortuna Metals Ltd requested a trading halt on January 29, 2026.
- The halt is pending an announcement about assay results from the Mkanda project in Malawi.
- The trading halt will last until the announcement is made or until February 2, 2026.
- The halt request was authorized by the Fortuna Metals Ltd board.
- There are no known objections to the trading halt being granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fulcrum Lithium Ltd (FUL) ORDINARY FULLY PAID |
Materials |
$7 |
Alkali Flats Phase 3 Drilling Progam Commenced
|
29 Jan 2026 9:26AM |
$0.120 |
$0.091 |
fallen by
24.17%
|
|
| Zelira Therapeutics Limited (ZLD) ORDINARY FULLY PAID |
Health Care |
$6 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 9:25AM |
$0.680 |
$0.500 |
fallen by
26.47%
|
|
ZLD - Price-sensitive ASX Announcement
Full Release
Key Points
- Zelira raised US$32,981,075 for its HOPE® 1 SPV.
- The fundraising is targeted at advancing the FDA clinical program.
- Zelira received a $1,070,000 R&D Tax Incentive refund.
- Net cash flow from operations for the quarter was $529k.
- The company’s cash position at quarter-end was $52k.
- Focus on clinical validation strategy and commercialization.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Indiana Resources Limited (IDA) ORDINARY FULLY PAID |
Materials |
$22 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jan 2026 9:24AM |
$0.048 |
$0.034 |
fallen by
29.17%
|
|
IDA - Price-sensitive ASX Announcement
Full Release
Key Points
- Assay results confirm continuity of gold structure at Minos.
- The company completed a comprehensive settlement with Tanzania.
- A capital return of $0.05 per share was executed.
- Closing cash balance at the end of the quarter was A$33.8 million.
- Appointment of Barbara Duggan as Head of Regional Exploration.
- Minos Gold Project identified as a key focus for strategic growth.
- No mining tenements were acquired or disposed of during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Critical Minerals Limited (ACM) ORDINARY FULLY PAID |
Materials |
$7 |
Proposed issue of securities - ACM
|
29 Jan 2026 9:24AM |
$0.081 |
$0.065 |
fallen by
19.75%
|
|
| Broken Hill Mines Limited (BHM) ORDINARY FULLY PAID |
Materials |
$117 |
December Quarterly Results Presentation
|
29 Jan 2026 9:24AM |
$1.290 |
$0.715 |
fallen by
44.57%
|
|
| Australian Critical Minerals Limited (ACM) ORDINARY FULLY PAID |
Materials |
$7 |
$3M Placement
|
29 Jan 2026 9:24AM |
$0.081 |
$0.065 |
fallen by
19.75%
|
|
ACM - Price-sensitive ASX Announcement
Full Release
Key Points
- Australian Critical Minerals Limited (ACM) announced a $3 million placement.
- The placement will fund exploration activities in Peru, including drilling at the Flint Gold-Silver Project.
- The Flint Project is a high-sulphidation epithermal gold-silver system located in Peru.
- ACM plans to issue 40 million new shares at $0.075 each to raise the funds.
- The placement will occur in two tranches, with Tranche 1 expected in early February 2026.
- Tranche 2 is subject to shareholder approval, to be sought in March 2026.
- Sandton Capital Advisory Pty Ltd will manage the placement and receive a 6% fee.
- The funds will also support ACM's general working capital needs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bannerman Energy Ltd (BMN) ORDINARY FULLY PAID |
Energy |
$756 |
Appendix 5B - Quarterly Cash Flow Report
|
29 Jan 2026 9:24AM |
$4.730 |
$3.640 |
fallen by
23.04%
|
|
BMN - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash outflow from operating activities: $2,435,000
- Net cash outflow from investing activities: $20,078,000
- Cash inflow from equity securities: $85,000
- Net cash outflow from financing activities: $71,000
- Cash and cash equivalents at quarter end: $89,278,000
- Estimated 9.4 quarters of funding available
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Winsome Resources Limited (WR1) ORDINARY FULLY PAID |
Materials |
$82 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jan 2026 9:24AM |
$0.635 |
$0.335 |
fallen by
47.24%
|
|
WR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Winsome Resources Limited entered into a binding Scheme Implementation Deed with Li-FT Power Limited for acquisition.
- Shareholders of Winsome will receive 0.107 of a Li-FT common share for each ordinary share of Winsome held.
- Winsome sold its offtake rights to lithium, cesium, and tantalum from the Case Lake Area to a subsidiary of Albemarle Corporation for C$1.8 million.
- Winsome has A$7.0 million in cash and 26.83 million shares in PWM valued at C$22.0 million as of December 31, 2025.
- Winsome secured an option to acquire additional claims adjoining the Adina project, covering 20km2.
- No major health and safety incidents occurred during 2025 field season.
- Infill drilling at Adina returned further high-grade, shallow intercepts.
- Eskan Consulting Group signed a Contribution Agreement with Natural Resources Canada for funding the Trans-Atikh Project.
- Net cash used in operating activities was A$4.3 million for the last six months ending December 2025.
- Net cash used in investing activities was A$7.0 million for the same period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID |
Health Care |
$47 |
Q2 FY26 Quarterly Investor Presentation & Webinar
|
29 Jan 2026 9:23AM |
$0.085 |
$0.078 |
fallen by
8.24%
|
|
MAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Core testing volumes up 90% year-over-year.
- Discontinued legacy products to focus on high-margin offerings.
- Developing a rich pipeline of live biotherapeutic assets.
- Microbiome Explorer adoption outperforming in the UK.
- Strategic focus on partnering for therapeutic developments.
- Advancements in diagnostics for gastrointestinal diseases.
- Building platform for personalized, microbiome-based healthcare.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ionic Rare Earths Limited (IXR) ORDINARY FULLY PAID |
Materials |
$63 |
December Quarterly Activities & Cash Flow Report
|
29 Jan 2026 9:23AM |
$0.545 |
$0.280 |
fallen by
48.62%
|
|
IXR - Price-sensitive ASX Announcement
Full Release
Key Points
- IonicRE emphasized the strategic importance of the Makuutu Heavy Rare Earths Project in Uganda.
- A mining licence for the Makuutu project was awarded, and the project is 'shovel-ready' for production.
- Ionic Technologies in the UK received a £12 million grant offer for its Belfast commercial plant.
- The company is advancing discussions on creating an ex-China rare earth supply chain.
- Significant financing activity included a successful rights issue and strategic investments.
- A capital consolidation was completed, reducing the number of shares.
- Corporate costs included expenditures on demonstration and exploratory activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Equatorial Resources Limited (EQX) ORDINARY FULLY PAID |
Materials |
$26 |
December 2025 Quarterly Report
|
29 Jan 2026 9:23AM |
$0.185 |
$0.200 |
risen by
8.11%
|
|
EQX - Price-sensitive ASX Announcement
Full Release
Key Points
- Equatorial Resources Limited presented its quarterly report for the period ending 31 December 2025.
- The company is engaged in an international arbitration against the Republic of Congo, regarding two iron ore projects.
- Final hearing for the arbitration was completed, with post-hearing submissions due in early 2026.
- Equatorial is claiming damages from Congo ranging from US$395 million to US$1.25 billion.
- The arbitration arose from unlawful measures taken by Congo against Equatorial's investments.
- Equatorial's financial position includes approximately $8.1 million in cash.
- The company is seeking clarity on its exploration permits in Guinea.
- Equatorial remains open to settlement discussions with Congo regarding the dispute.
- No payments were made for mining exploration activities during the quarter.
- Equatorial has interests in several mining exploration permits, some of which are awaiting renewal.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Champion Iron Limited (CIA) ORDINARY FULLY PAID |
Materials |
$2,522 |
Quarterly Activities Report - Dec 31, 2025
|
29 Jan 2026 9:22AM |
$6.340 |
$4.730 |
fallen by
25.39%
|
|
CIA - Price-sensitive ASX Announcement
Full Release
Key Points
- Champion Iron Limited reports its operational and financial results for the financial third quarter ended December 31, 2025.
- The quarterly production was 3.7 million wmt of high-grade 66.5% Fe concentrate.
- Champion Iron generated revenues of $472 million and net income of $65 million.
- DRPF project initial commissioning is underway with plans to deliver the first shipment by the end of calendar H1/2026.
- The company plans to diversify its portfolio with the acquisition of Rana Gruber.
- Champion Iron anticipates the Kami project definitive feasibility study to be completed by the end of the 2026 calendar year.
- The company reduced iron ore concentrate inventories at Bloom Lake by 1.1 million wmt.
- Champion continues to evaluate growth opportunities and capital allocation strategies to optimize shareholder returns.
- A webcast and conference call to discuss the results was scheduled for January 29, 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Archer Materials Limited (AXE) ORDINARY FULLY PAID |
Information Technology |
$83 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 9:22AM |
$0.390 |
$0.325 |
fallen by
16.67%
|
|
AXE - Price-sensitive ASX Announcement
Full Release
Key Points
- Improved quantum state readout for Archer’s carbon qubit materials.
- Signed a collaboration agreement with Emergence Quantum.
- Agreement with CSIRO to develop quantum machine learning models.
- Biochip met clinical standards for blood potassium testing.
- End of quarter cash balance of $10.3 million, with no debt.
- Appointment of Andrew Just as Non-Executive Director.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
